Novartis delivered strong sales growth, margin expansion and breakthrough innovation launching five NMEs in 2019

    NEXT STORY
    Trillium Closes US$117 Million Public Offering of Common Shares and Series II Non-Voting Convertible First Preferred Shares
    PREV STORY
    The Europe Specialty hospitals market is expected to reach US$ 157.4 Bn in 2027 from US$ 120.9 in 2018
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Dova Pharmaceuticals Reports First Quarter 2019 Operating and Financial Results

    author_avatar
    NASDAQ Market News

    Sandoz resubmits biosimilar pegfilgrastim application to US FDA

    author_avatar
    NASDAQ Market News

    UroGen Pharma Announces Closing of Upsized Public Offering of Ordinary Shares and Full Exercise of Underwriters’ Option

    RA’ANANA, Israel and NEW YORK, Jan. 23, 2018 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. ...

    author_avatar
    NASDAQ Market News